Skip to content
Hydrocortamate
Magnacort (hydrocortamate) is a small molecule pharmaceutical. Hydrocortamate was first approved as Magnacort on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydrocortamate hydrochloride
Tradename
Company
Number
Date
Products
MAGNACORTMylanN-010554 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
84 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R524755223
Postoperative painD010149G89.181416
Chronic painD059350HP_0012532325
Postoperative nausea and vomitingD020250EFO_0004888112
Rotator cuff injuriesD000070636M75.1112
Pain managementD05940822
ToothacheD014098K08.89112
Rib fracturesD01225311
Colonic neoplasmsD003110C1811
Rectal neoplasmsD01200411
Show 19 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Low back painD017116HP_0003419M54.51416
OsteoarthritisD010003EFO_0002506M15-M19112
Anterior cruciate ligament injuriesD000070598111
Shoulder painD020069HP_0030834M25.5111
Multiple myelomaD009101C90.011
LymphomaD008223C85.911
Head and neck neoplasmsD00625811
MucositisD052016EFO_100189811
VomitingD014839HP_0002013R11.111
NauseaD009325HP_0002018R11.011
Show 4 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Musculoskeletal painD059352112
Corneal injuriesD065306HP_000055911
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients55
Drug interactionsD004347112
Ankle fracturesD064386S82.511
Substance-related disordersD019966EFO_0003890F1311
Hepatic insufficiencyD04855011
Renal insufficiencyD051437HP_0000083N1911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C5011
Corneal diseasesD003316H18.911
Acute painD059787R5211
ThyroidectomyD01396511
Soft tissue injuriesD01769511
LacerationsD02212511
MethodsD00872211
Tooth migrationD01408511
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHYDROCORTAMATE
INNhydrocortamate
Description
Hydrocortamate is a glycinyl ester, an 11beta-hydroxy steroid, a 17alpha-hydroxy steroid, a glucocorticoid, a 3-oxo-Delta(4) steroid and a tertiary alpha-hydroxy ketone. It has a role as an anti-inflammatory drug and an immunosuppressive agent. It is functionally related to a cortisone.
Classification
Small molecule
Drug classcortisone derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
Identifiers
PDB
CAS-ID76-47-1
RxCUI
ChEMBL IDCHEMBL1201263
ChEBI ID50851
PubChem CID84088
DrugBankDB00769
UNII IDY3N00BK5WK (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 8 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
246 adverse events reported
View more details